{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:03:24Z","timestamp":1784293404160,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100031957","name":"kaleo, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40272-026-00752-7","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:32:03Z","timestamp":1781796723000},"page":"373-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epinephrine Underuse for Anaphylaxis in Infants and Toddlers: A Practical Review for Pediatricians"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3270-9108","authenticated-orcid":false,"given":"Stephanie","family":"Leeds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Anagnostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-6164","authenticated-orcid":false,"given":"Michael","family":"Pistiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-4100","authenticated-orcid":false,"given":"Jay","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8848-1678","authenticated-orcid":false,"given":"Nicole B.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-3359","authenticated-orcid":false,"given":"Rachael","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-9092","authenticated-orcid":false,"given":"Julie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"752_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.01.021","author":"TE Dribin","year":"2025","unstructured":"Dribin TE, Muraro A, Camargo CA Jr., Turner PJ, Wang J, Roberts G, et al. Anaphylaxis definition, overview, and clinical support tool: 2024 consensus report-a GA(2)LEN project. J Allergy Clin Immunol. 2025;156(2):406\u2013417.e6. https:\/\/doi.org\/10.1016\/j.jaci.2025.01.021.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"752_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","volume":"132","author":"DBK Golden","year":"2024","unstructured":"Golden DBK, Wang J, Waserman S, Akin C, Campbell RL, Ellis AK, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124\u201376. https:\/\/doi.org\/10.1016\/j.anai.2023.09.015.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"752_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","volume":"145","author":"MS Shaker","year":"2020","unstructured":"Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082\u2013123. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.017.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"752_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jaip.2019.07.018","volume":"8","author":"KA Michelson","year":"2020","unstructured":"Michelson KA, Dribin TE, Vyles D, Neuman MI. Trends in emergency care for anaphylaxis. J Allergy Clin Immunol Pract. 2020;8(2):767\u20138. https:\/\/doi.org\/10.1016\/j.jaip.2019.07.018.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"752_CR5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jaip.2023.01.029","volume":"11","author":"TE Dribin","year":"2023","unstructured":"Dribin TE, Neuman MI, Schnadower D, Sampson HA, Porter JJ, Michelson KA. Trends and variation in pediatric anaphylaxis care from 2016 to 2022. J Allergy Clin Immunol Pract. 2023;11(4):1184\u20139. https:\/\/doi.org\/10.1016\/j.jaip.2023.01.029.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"752_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.18176\/jiaci.0426","volume":"29","author":"A Alvarez Perea","year":"2019","unstructured":"Alvarez Perea A, Fuentes Aparicio V, Cabrera Freitag P, Infante S, Zapatero L, Zubeldia JM, et al. Is self-injectable epinephrine being used by children with food allergy? J Investig Allergol Clin Immunol. 2019;29(6):461\u20133. https:\/\/doi.org\/10.18176\/jiaci.0426.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"752_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaip.2023.02.002","volume":"11","author":"TE Dribin","year":"2023","unstructured":"Dribin TE, Waserman S, Turner PJ. Who needs epinephrine? Anaphylaxis, autoinjectors, and parachutes. J Allergy Clin Immunol Pract. 2023;11(4):1036\u201346. https:\/\/doi.org\/10.1016\/j.jaip.2023.02.002.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"752_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10903127.2017.1402110","volume":"22","author":"E Andrew","year":"2018","unstructured":"Andrew E, Nehme Z, Bernard S, Smith K. Pediatric anaphylaxis in the prehospital setting: incidence, characteristics, and management. Prehosp Emerg Care. 2018;22(4):445\u201351. https:\/\/doi.org\/10.1080\/10903127.2017.1402110.","journal-title":"Prehosp Emerg Care"},{"issue":"6","key":"752_CR9","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.jaci.2016.02.016","volume":"137","author":"E Hochstadter","year":"2016","unstructured":"Hochstadter E, Clarke A, De Schryver S, La Vieille S, Alizadehfar R, Joseph L, et al. Increasing visits for anaphylaxis and the benefits of early epinephrine administration: a\u00a04-year study at a pediatric emergency department in Montreal, Canada. J Allergy Clin Immunol. 2016;137(6):1888\u201390. https:\/\/doi.org\/10.1016\/j.jaci.2016.02.016.","journal-title":"J Allergy Clin Immunol"},{"key":"752_CR10","unstructured":"In brief: Auvi-Q epinephrine auto-injector for infants and toddlers. Med Lett Drugs Ther. 2018;60(1547):83."},{"issue":"2","key":"752_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.anai.2013.06.002","volume":"111","author":"ES Edwards","year":"2013","unstructured":"Edwards ES, Gunn R, Simons ER, Carr K, Chinchilli VM, Painter G, et al. Bioavailability of epinephrine from Auvi-Q compared with EpiPen. Ann Allergy Asthma Immunol. 2013;111(2):132\u20137. https:\/\/doi.org\/10.1016\/j.anai.2013.06.002.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"752_CR12","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/bcp.15545","volume":"89","author":"T Duvauchelle","year":"2023","unstructured":"Duvauchelle T, Robert P, Donazzolo Y, Loyau S, Orlandini B, Lehert P, et al. Bioavailability and cardiovascular effects of adrenaline administered by Anapen 500\u2009\u03bcg auto-injector in healthy volunteers. Br J Clin Pharmacol. 2023;89(3):1012\u20139. https:\/\/doi.org\/10.1111\/bcp.15545.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"752_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.anai.2024.04.033","volume":"133","author":"DA Dworaczyk","year":"2024","unstructured":"Dworaczyk DA, Hunt A, Di Spirito M, Lor M, Rance K, van Haarst AD. Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestion. Ann Allergy Asthma Immunol. 2024;133(2):186\u201393. https:\/\/doi.org\/10.1016\/j.anai.2024.04.033.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"752_CR14","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/j.jaip.2024.05.018","volume":"12","author":"A Handorf","year":"2024","unstructured":"Handorf A, Roy IR, Cohen A, Camargo CA Jr., Dribin TE, Pistiner M. Development and evaluation of modified criteria for infant and toddler anaphylaxis. J Allergy Clin Immunol Pract. 2024;12(8):2026\u201334. https:\/\/doi.org\/10.1016\/j.jaip.2024.05.018.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"752_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jaip.2020.11.005","volume":"9","author":"M Pistiner","year":"2021","unstructured":"Pistiner M, Mendez-Reyes JE, Eftekhari S, Carver M, Lieberman J, Wang J, et al. Caregiver-reported presentation of severe food-induced allergic reactions in infants and toddlers. J Allergy Clin Immunol Pract. 2021;9(1):311\u201320. https:\/\/doi.org\/10.1016\/j.jaip.2020.11.005.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"752_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.anai.2020.09.012","volume":"126","author":"B Glassberg","year":"2021","unstructured":"Glassberg B, Nowak-Wegrzyn A, Wang J. Factors contributing to underuse of epinephrine autoinjectors in pediatric patients with food allergy. Ann Allergy Asthma Immunol. 2021;126(2):175\u20139. https:\/\/doi.org\/10.1016\/j.anai.2020.09.012.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"752_CR17","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.jaip.2021.01.038","volume":"9","author":"LM Miles","year":"2021","unstructured":"Miles LM, Ratnarajah K, Gabrielli S, Abrams EM, Protudjer JLP, B\u00e9gin P, et al. Community use of epinephrine for the treatment of anaphylaxis: a review and meta-analysis. J Allergy Clin Immunol Pract. 2021;9(6):2321\u201333. https:\/\/doi.org\/10.1016\/j.jaip.2021.01.038.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"752_CR18","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1016\/j.jaip.2020.12.063","volume":"9","author":"N Cohen","year":"2021","unstructured":"Cohen N, Test G, Scolnik D. Predictors of epinephrine undertreatment in anaphylaxis-the experience of a busy North American tertiary care pediatric emergency department. J Allergy Clin Immunol Pract. 2021;9(5):2090\u20132. https:\/\/doi.org\/10.1016\/j.jaip.2020.12.063.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"752_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jaip.2023.10.049","volume":"12","author":"M Pistiner","year":"2024","unstructured":"Pistiner M, Mendez-Reyes JE, Eftekhari S, Carver M, Lieberman J, Wang J, et al. Factors associated with epinephrine use in the treatment of anaphylaxis in infants and toddlers. J Allergy Clin Immunol Pract. 2024;12(2):364\u201371. https:\/\/doi.org\/10.1016\/j.jaip.2023.10.049.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"752_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/2333794x19854960","volume":"6","author":"S Owusu-Ansah","year":"2019","unstructured":"Owusu-Ansah S, Badaki O, Perin J, Stevens M, Anders J, Wood R. Under prescription of epinephrine to Medicaid patients in the pediatric emergency department. Glob Pediatr Health. 2019;6:2333794x19854960. https:\/\/doi.org\/10.1177\/2333794x19854960.","journal-title":"Glob Pediatr Health"},{"issue":"4","key":"752_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.anai.2018.06.010","volume":"121","author":"CM Warren","year":"2018","unstructured":"Warren CM, Zaslavsky JM, Kan K, Spergel JM, Gupta RS. Epinephrine auto-injector carriage and use practices among US children, adolescents, and adults. Ann Allergy Asthma Immunol. 2018;121(4):479\u201389. https:\/\/doi.org\/10.1016\/j.anai.2018.06.010.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"752_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2500\/aap.2021.42.200099","volume":"42","author":"JS Cohen","year":"2021","unstructured":"Cohen JS, Agbim C, Hrdy M, Mottla ME, Goyal MK, Breslin K. Epinephrine autoinjector prescription filling after pediatric emergency department discharge. Allergy Asthma Proc. 2021;42(2):142\u20136. https:\/\/doi.org\/10.2500\/aap.2021.42.200099.","journal-title":"Allergy Asthma Proc"},{"key":"752_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ajem.2020.04.070","volume":"44","author":"WC Sokoloff","year":"2021","unstructured":"Sokoloff WC, O\u2019Connell NC, Olson PG, Fein DM. Fill rates and access to self-injectable epinephrine prescribed in a pediatric emergency department. Am J Emerg Med. 2021;44:378\u201382. https:\/\/doi.org\/10.1016\/j.ajem.2020.04.070.","journal-title":"Am J Emerg Med"},{"issue":"5","key":"752_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1067\/mai.2000.106042","volume":"105","author":"FE Simons","year":"2000","unstructured":"Simons FE, Gu X, Simons KJ. Outdated EpiPen and EpiPen Jr autoinjectors: past their prime? J Allergy Clin Immunol. 2000;105(5):1025\u201330. https:\/\/doi.org\/10.1067\/mai.2000.106042.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"752_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2021-001742","volume":"11","author":"A Ziyar","year":"2022","unstructured":"Ziyar A, Kwon J, Li A, Naderi A, Jean T. Improving epinephrine autoinjector usability and carriage frequency among patients at risk of anaphylaxis: a quality improvement initiative. BMJ Open Qual. 2022;11(3):e001742. https:\/\/doi.org\/10.1136\/bmjoq-2021-001742.","journal-title":"BMJ Open Qual"},{"issue":"7","key":"752_CR26","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.jaip.2019.03.021","volume":"7","author":"J Portnoy","year":"2019","unstructured":"Portnoy J, Wade RL, Kessler C. Patient carrying time, confidence, and training with epinephrine autoinjectors: the RACE survey. J Allergy Clin Immunol Pract. 2019;7(7):2252\u201361. https:\/\/doi.org\/10.1016\/j.jaip.2019.03.021.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"752_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jaip.2024.11.006","volume":"13","author":"E Zhang","year":"2025","unstructured":"Zhang E, Sicherer S, Agyemang A. Proper use of epinephrine autoinjectors is related to device type, prior physical demonstration, and sociodemographic factors. J Allergy Clin Immunol Pract. 2025;13(2):418\u201320. https:\/\/doi.org\/10.1016\/j.jaip.2024.11.006.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"752_CR28","unstructured":"Kaleo, Inc. AUVI-Q\u00ae (epinephrine injection, USP). Full Prescribing Information. Richmond, VA: Kaleo, Inc.; 2024."},{"issue":"12","key":"752_CR29","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1111\/all.12262","volume":"68","author":"L Chad","year":"2013","unstructured":"Chad L, Ben-Shoshan M, Asai Y, Cherkaoui S, Alizadehfar R, St-Pierre Y, et al. A majority of parents of children with peanut allergy fear using the epinephrine auto-injector. Allergy. 2013;68(12):1605\u20139. https:\/\/doi.org\/10.1111\/all.12262.","journal-title":"Allergy"},{"issue":"3","key":"752_CR30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36429","volume":"15","author":"M Nayaz","year":"2023","unstructured":"Nayaz M, Mohamed A, Nawaz A. Accidental digital ischemia by an epinephrine autoinjector. Cureus. 2023;15(3):e36429. https:\/\/doi.org\/10.7759\/cureus.36429.","journal-title":"Cureus"},{"issue":"1","key":"752_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.iac.2021.09.009","volume":"42","author":"JC Collie","year":"2022","unstructured":"Collie JC, Lockey RF. Patient communications: why is it important to quickly use epinephrine at the onset of symptoms and signs of anaphylaxis? Immunol Allergy Clin North Am. 2022;42(1):201\u201317. https:\/\/doi.org\/10.1016\/j.iac.2021.09.009.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"752_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000477566","volume":"173","author":"V Cardona","year":"2017","unstructured":"Cardona V, Ferr\u00e9-Ybarz L, Guilarte M, Moreno-P\u00e9rez N, G\u00f3mez-Gal\u00e1n C, Alcoceba-Borr\u00e0s E, et al. Safety of adrenaline use in anaphylaxis: a multicentre register. Int Arch Allergy Immunol. 2017;173(3):171\u20137. https:\/\/doi.org\/10.1159\/000477566.","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"752_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.70085","volume":"15","author":"M Ebisawa","year":"2025","unstructured":"Ebisawa M, Muraro A, Worm M, Katelaris CH, Pouessel G, Ring J, et al. Optimizing adrenaline administration in anaphylaxis: clinical practice considerations and safety insights. Clin Transl Allergy. 2025;15(8):e70085. https:\/\/doi.org\/10.1002\/clt2.70085.","journal-title":"Clin Transl Allergy"},{"issue":"6","key":"752_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/emermed-2016-205742","volume":"34","author":"A El Turki","year":"2017","unstructured":"El Turki A, Smith H, Llewellyn C, Jones CJ. A systematic review of patients\u2019, parents\u2019 and healthcare professionals\u2019 adrenaline auto-injector administration techniques. Emerg Med J. 2017;34(6):403\u201316. https:\/\/doi.org\/10.1136\/emermed-2016-205742.","journal-title":"Emerg Med J"},{"issue":"8","key":"752_CR35","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/pcc.0000000000001197","volume":"18","author":"NO Chime","year":"2017","unstructured":"Chime NO, Riese VG, Scherzer DJ, Perretta JS, McNamara L, Rosen MA, et al. Epinephrine auto-injector versus drawn up epinephrine for anaphylaxis management: a scoping review. Pediatr Crit Care Med. 2017;18(8):764\u20139. https:\/\/doi.org\/10.1097\/pcc.0000000000001197.","journal-title":"Pediatr Crit Care Med"},{"key":"752_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/dhps.S121733","volume":"9","author":"LS Posner","year":"2017","unstructured":"Posner LS, Camargo CA Jr. Update on the usage and safety of epinephrine auto-injectors, 2017. Drug Healthc Patient Saf. 2017;9:9\u201318. https:\/\/doi.org\/10.2147\/dhps.S121733.","journal-title":"Drug Healthc Patient Saf."},{"issue":"6","key":"752_CR37","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.anai.2017.03.017","volume":"118","author":"H Kim","year":"2017","unstructured":"Kim H, Dinakar C, McInnis P, Rudin D, Benain X, Daley W, et al. Inadequacy of current pediatric epinephrine autoinjector needle length for use in infants and toddlers. Ann Allergy Asthma Immunol. 2017;118(6):719\u201325. https:\/\/doi.org\/10.1016\/j.anai.2017.03.017.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"752_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/jaa.S286692","volume":"14","author":"A Carlisle","year":"2021","unstructured":"Carlisle A, Lieberman J. Clinical management of infant anaphylaxis. J Asthma Allergy. 2021;14:821\u20137. https:\/\/doi.org\/10.2147\/jaa.S286692.","journal-title":"J Asthma Allergy."},{"key":"752_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13601-018-0230-y","volume":"8","author":"R Chooniedass","year":"2018","unstructured":"Chooniedass R, Temple B, Martin D, Becker A. A qualitative study exploring parents\u2019 experiences with epinephrine use for their child\u2019s anaphylactic reaction. Clin Transl Allergy. 2018;8:43. https:\/\/doi.org\/10.1186\/s13601-018-0230-y.","journal-title":"Clin Transl Allergy."},{"key":"752_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2025.03.027","author":"A Anagnostou","year":"2025","unstructured":"Anagnostou A, Abrams EM, Anderson WC, Carver M, Eftekhari S, Golden DBK, et al. Development of a validated, updated North American pediatric food allergy anaphylaxis management plan. Ann Allergy Asthma Immunol. 2025;135(1):71\u201378.e4. https:\/\/doi.org\/10.1016\/j.anai.2025.03.027.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"752_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.anai.2020.11.010","volume":"126","author":"JA Lieberman","year":"2021","unstructured":"Lieberman JA, Camargo CA Jr, Pistiner M, Wang J. Pediatrician perspectives on symptom presentation and treatment of acute allergic reactions. Ann Allergy Asthma Immunol. 2021;126(3):273\u20137. https:\/\/doi.org\/10.1016\/j.anai.2020.11.010.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"752_CR42","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-0194","volume":"140","author":"SH Sicherer","year":"2017","unstructured":"Sicherer SH, Allen K, Lack G, Taylor SL, Donovan SM, Oria M. Critical issues in food allergy: a National Academies consensus report. Pediatrics. 2017;140(2):e20170194. https:\/\/doi.org\/10.1542\/peds.2017-0194.","journal-title":"Pediatrics"},{"issue":"2","key":"752_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/all.15032","volume":"77","author":"A Muraro","year":"2022","unstructured":"Muraro A, Worm M, Alviani C, Cardona V, DunnGalvin A, Garvey LH, et al. EAACI guidelines: anaphylaxis (2021 update). Allergy. 2022;77(2):357\u201377. https:\/\/doi.org\/10.1111\/all.15032.","journal-title":"Allergy"},{"issue":"1","key":"752_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/all.16345","volume":"80","author":"AF Santos","year":"2025","unstructured":"Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, et al. EAACI guidelines on the management of IgE-mediated food allergy. Allergy. 2025;80(1):14\u201336. https:\/\/doi.org\/10.1111\/all.16345.","journal-title":"Allergy"},{"issue":"1","key":"752_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaip.2014.07.004","volume":"3","author":"JT Fleming","year":"2015","unstructured":"Fleming JT, Clark S, Camargo CA Jr, Rudders SA. Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract. 2015;3(1):57\u201362. https:\/\/doi.org\/10.1016\/j.jaip.2014.07.004.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1 Pt 1","key":"752_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1067\/mai.2000.106041","volume":"106","author":"MS Gold","year":"2000","unstructured":"Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol. 2000;106(1 Pt 1):171\u20136. https:\/\/doi.org\/10.1067\/mai.2000.106041.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"752_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12289","volume":"13","author":"E Clark","year":"2023","unstructured":"Clark E, Kase Tanno L, Vo T, Blanc B, Demoly P, Caimmi D. Anaphylaxis management in a French pediatric emergency department: lessons from the ANA-PED study. Clin Transl Allergy. 2023;13(8):e12289. https:\/\/doi.org\/10.1002\/clt2.12289.","journal-title":"Clin Transl Allergy"},{"issue":"10","key":"752_CR48","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.jaip.2024.06.045","volume":"12","author":"M Theodorakakis","year":"2024","unstructured":"Theodorakakis M, Machado S, Andre M, Hazi A, Ongaro Z, Pan L, et al. Parental experience administering epinephrine for systemic reactions during infant and toddler oral food challenges. J Allergy Clin Immunol Pract. 2024;12(10):2838\u201341. https:\/\/doi.org\/10.1016\/j.jaip.2024.06.045.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"752_CR49","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-4005","volume":"139","author":"J Wang","year":"2017","unstructured":"Wang J, Sicherer SH. Guidance on completing a written allergy and anaphylaxis emergency plan. Pediatrics. 2017;139(3):e20164005. https:\/\/doi.org\/10.1542\/peds.2016-4005.","journal-title":"Pediatrics"},{"key":"752_CR50","unstructured":"American Academy of Pediatrics. Allergy and anaphylaxis emergency plan. 2017. https:\/\/downloads.aap.org\/AAP\/PDF\/AAP_Allergy_and_Anaphylaxis_Emergency_Plan.pdf. Accessed 29 Apr 2025."},{"key":"752_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9837508","volume":"2017","author":"F Fernandez-Mendez","year":"2017","unstructured":"Fernandez-Mendez F, Saez-Gallego NM, Barcala-Furelos R, Abelairas-Gomez C, Padron-Cabo A, Perez-Ferreiros A, et al. Learning and treatment of anaphylaxis by laypeople: a simulation study using pupilar technology. BioMed Res Int. 2017;2017:9837508. https:\/\/doi.org\/10.1155\/2017\/9837508.","journal-title":"BioMed Res Int"},{"issue":"1","key":"752_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/1942602x221110083","volume":"38","author":"A Keller","year":"2023","unstructured":"Keller A, Morse B, Conroy M. Food allergies and anaphylaxis in the community: the school nurse\u2019s role. NASN Sch Nurse. 2023;38(1):41\u20136. https:\/\/doi.org\/10.1177\/1942602x221110083.","journal-title":"NASN Sch Nurse"},{"issue":"2","key":"752_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.alit.2014.10.005","volume":"64","author":"K Sasaki","year":"2015","unstructured":"Sasaki K, Sugiura S, Matsui T, Nakagawa T, Nakata J, Kando N, et al. A workshop with practical training for anaphylaxis management improves the self-efficacy of school personnel. Allergol Int. 2015;64(2):156\u201360. https:\/\/doi.org\/10.1016\/j.alit.2014.10.005.","journal-title":"Allergol Int"},{"issue":"1","key":"752_CR54","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaip.2018.05.015","volume":"7","author":"A Tsuang","year":"2019","unstructured":"Tsuang A, Atal Z, Demain H, Patrick K, Pistiner M, Wang J. Benefits of school nurse training sessions for food allergy and anaphylaxis management. J Allergy Clin Immunol Pract. 2019;7(1):309\u201311. https:\/\/doi.org\/10.1016\/j.jaip.2018.05.015.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"752_CR55","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1016\/j.jaip.2022.09.015","volume":"10","author":"C Prosty","year":"2022","unstructured":"Prosty C, Colli MD, Gabrielli S, Clarke AE, Morris J, Gravel J, et al. Impact of reaction setting on the management, severity, and outcome of pediatric food-induced anaphylaxis: a cross-sectional study. J Allergy Clin Immunol Pract. 2022;10(12):3163\u201371. https:\/\/doi.org\/10.1016\/j.jaip.2022.09.015.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"752_CR56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11845-023-03414-6","volume":"193","author":"M Crealey","year":"2024","unstructured":"Crealey M, Byrne A. Factors influencing accidental food allergic reactions in schools and preschools. Ir J Med Sci. 2024;193(1):313\u20139. https:\/\/doi.org\/10.1007\/s11845-023-03414-6.","journal-title":"Ir J Med Sci"},{"issue":"5","key":"752_CR57","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jaci.2021.03.042","volume":"148","author":"N Patel","year":"2021","unstructured":"Patel N, Chong KW, Yip AYG, Ierodiakonou D, Bartra J, Boyle RJ, et al. Use of multiple epinephrine doses in anaphylaxis: a systematic review and meta-analysis. J Allergy Clin Immunol. 2021;148(5):1307\u201315. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.042.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"752_CR58","doi-asserted-by":"publisher","first-page":"e1355","DOI":"10.1097\/pec.0000000000002620","volume":"38","author":"K McCans","year":"2022","unstructured":"McCans K, Varma S, Ramgopal S, Martin-Gill C, Owusu-Ansah S. Variation in prehospital protocols for pediatric respiratory distress management in the United States. Pediatr Emerg Care. 2022;38(7):e1355\u201361. https:\/\/doi.org\/10.1097\/pec.0000000000002620.","journal-title":"Pediatr Emerg Care"},{"key":"752_CR59","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7181.1","volume":"4","author":"AM Irani","year":"2015","unstructured":"Irani AM, Akl EG. Management and prevention of anaphylaxis. F1000Res. 2015;4:F1000 Faculty Rev-492. https:\/\/doi.org\/10.12688\/f1000research.7181.1.","journal-title":"F1000Res"},{"issue":"4","key":"752_CR60","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jaip.2022.12.047","volume":"11","author":"AF Russell","year":"2023","unstructured":"Russell AF, Bingemann TA, Cooke AT, Ponda P, Pistiner M, Jean T, et al. The need for required stock epinephrine in all schools: a work group report of the AAAAI Adverse Reactions to Foods Committee. J Allergy Clin Immunol Pract. 2023;11(4):1068\u201382. https:\/\/doi.org\/10.1016\/j.jaip.2022.12.047.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"752_CR61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jacig.2022.06.003","volume":"1","author":"MK Vetter","year":"2022","unstructured":"Vetter MK, Newell AC, Huntwork MP, Carlson JC. Availability of stock epinephrine in schools is needed to address health disparities in anaphylaxis. J Allergy Clin Immunol Glob. 2022;1(4):325\u20136. https:\/\/doi.org\/10.1016\/j.jacig.2022.06.003.","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"2","key":"752_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.12.332","volume":"151","author":"S Lowery","year":"2023","unstructured":"Lowery S, Menasco A, Goertz J, Hoyt A. Stock epinephrine laws pertaining to early childcare centers are heterogenous across the United States. J Allergy Clin Immunol. 2023;151(2):AB104. https:\/\/doi.org\/10.1016\/j.jaci.2022.12.332.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"752_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13223-025-00977-0","volume":"21","author":"B Sharma","year":"2025","unstructured":"Sharma B, Ayers S, Huang J, Gerdts J, Waserman S, Levinson AJ. Online food allergy and anaphylaxis education for school personnel is effective and scalable: experience with the Allergyaware e-learning portal from 2015 to 2022. Allergy Asthma Clin Immunol. 2025;21(1):30. https:\/\/doi.org\/10.1186\/s13223-025-00977-0.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"752_CR64","unstructured":"Anaphylaxis teaching tools and resources. https:\/\/education.acaai.org\/AnaphylaxisSlides. Accessed 29 July 2025."},{"key":"752_CR65","unstructured":"Anaphylaxis guide and resources. https:\/\/allergyasthmanetwork.org\/anaphylaxis\/infant-anaphylaxis\/. Accessed 13 Apr 2026."},{"key":"752_CR66","unstructured":"Education - Healthcare professionals. https:\/\/www.foodallergyawareness.org\/education-in-schools\/education-downloads\/healthcare-professionals\/. Accessed 29 July 2025."},{"key":"752_CR67","unstructured":"Anaphylaxis, urticaria, and angioedema. https:\/\/education.aaaai.org\/anaphylaxis-urticaria-and-angioedema. Accessed 29 July 2025."},{"key":"752_CR68","unstructured":"Asthma management education. https:\/\/aafa.org\/programs\/education-programs\/asthma-management-education\/. Accessed 29 July 2025."},{"key":"752_CR69","unstructured":"FAMP-IT clinician support tool. https:\/\/famp-it.org\/. Accessed 29 July 2025."},{"key":"752_CR70","unstructured":"American Academy of Pediatrics. Allergy and anaphylaxis emergency plan (Spanish). 2017. https:\/\/downloads.aap.org\/AAP\/PDF\/AAEP.Spanish.PDF.rm.1.26.21.pdf. Accessed 3 Jun 2026."},{"key":"752_CR71","unstructured":"Training for babysitters and caregivers. https:\/\/kidswithfoodallergies.org\/living-with-food-allergies\/planning-for-school\/training-for-babysitters-and-caregivers\/. Accessed 3 Jun 2026."},{"key":"752_CR72","unstructured":"Food allergy anaphylaxis in infants and toddlers. https:\/\/aafa.org\/asthma-allergy-research\/our-research\/food-allergy-anaphylaxis-in-infants\/. Accessed 3 June 2026."},{"key":"752_CR73","unstructured":"The AAP parenting website. https:\/\/www.healthychildren.org\/English\/Pages\/default.aspx. Accessed 3 Jun 2026."},{"key":"752_CR74","unstructured":"Kids with Food Allergies. https:\/\/kidswithfoodallergies.org\/. Accessed 3 Jun 2026."},{"key":"752_CR75","unstructured":"Food Allergy & Anaphylaxis Connection Team. https:\/\/www.foodallergyawareness.org\/. Accessed 3 Jun 2026."},{"key":"752_CR76","unstructured":"Allergy & Asthma Network. https:\/\/allergyasthmanetwork.org\/. Accessed 3 June 2026."},{"key":"752_CR77","unstructured":"American College of Allergy, Asthma & Immunology. Using epinephrine. https:\/\/acaai.org\/allergies\/management-treatment\/epinephrine-auto-injector\/. Accessed 3 Jun 2026."},{"key":"752_CR78","unstructured":"American Academy of Allergy, Asthma & Immunology. Conditions library. https:\/\/www.aaaai.org\/tools-for-the-public\/conditions-library. Accessed 3 Jun 2026."},{"key":"752_CR79","unstructured":"FAMPIT-Family. https:\/\/fampitfamily.org\/. Accessed 3 Jun 2026."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00752-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00752-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00752-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:11:02Z","timestamp":1784290262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-026-00752-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00752-7","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stephanie Leeds: consultancy fees from Regeneron and DBV Technologies; and received research funding from FARE. Aikaterini Anagnostou: institutional funding from Novartis, Aquestive, ALK, and AAFA; advisory board member for Novartis, Genentech, ALK, and Bryn; and consultation\/speaker fees from ALK, EPG Health, MJH, Adelphi, Aimmune Therapeutics, DBV Technologies, Genentech, FARE, Medscape, kaleo, Inc., Stallergenes, and Innovation Horizons. Michael Pistiner: consultant\/advisor for AAFA, FARE, AAN, kaleo, Inc., DBV Technologies, Bryn Pharma, Genentech, Novartis, Aimmune, Food Graph, and Anjo; received funding from kaleo, Inc., ARS, DBV Technologies, Kenvue, Aquestive, Stallergenes Greer, National Peanut Board, and Egg Nutrition Center; and is co-founder of AllergyHome and Allergy Certified Training. Jay Lieberman: grant from DBV (money to institution); consulting\/advisor fees from ARS, Aquestive, kaleo, Inc., Genentech; Adjudication for Amgen, Celldex; and leadership or fiduciary role in American Board of Allergy and Immunology, ACAAI, and Joint Task Force for Practice Parameters. Nicole B. Ramsey: grants to institution from Pfizer, Food Allergy Fund and Bristol Myers Squibb Foundation; and honoraria from the American Academy of Pediatrics and Blackhealth Matters, speaker and consultant to Guidepoint and KnowledgeGate. Rachael Griffiths: employee of kaleo, Inc. Julie Wang: grants or contracts from NIH, Aimmune Therapeutics, Regeneron, and Siolta Therapeutics; honoraria from Medscape and DBV Technologies; support for attending AAAAI, ACAAI, and AAP meetings; participation on a data safety monitoring board or advisory board for ALK-Abell\u00f3, Jubilant HollisterStier, and Novartis; consulting\/advising fees from kaleo, Inc.; and leadership or fiduciary role in AAP (immediate past chair, executive committee, Section on Allergy and Immunology) and AAAAI (chair, annual meeting programming committee).","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors (Stephanie Leeds, Aikaterini Anagnostou, Michael Pistiner, Jay Lieberman, Nicole B. Ramsey, Rachael Griffiths, and Julie Wang) contributed equally to conceptualization, writing \u2013 original draft, and writing \u2013 review and editing. All authors have read and approved the final version of the manuscript and agree to be accountable for all aspects of the work.","order":7,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}